Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2019

Aug 06, 2019

BUY
$65.7 - $83.98 $5.41 Million - $6.91 Million
82,340 Added 39.6%
290,290 $21.1 Million
Q3 2017

Nov 01, 2017

BUY
$69.85 - $89.22 $14.5 Million - $18.6 Million
207,950
207,950 $18.5 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $318B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Fidelity National Financial, Inc. Portfolio

Follow Fidelity National Financial, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fidelity National Financial, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Fidelity National Financial, Inc. with notifications on news.